Presentations and Reports

Presentations

Cymat Investor Presentation

January 2022

~|file-pdf-o~|font-awesome~|outline

~|icon_printer-alt~|elegant-themes~|solid

~|icon_download~|elegant-themes~|solid

Financial Reports

Cymat’s fiscal year commences on the first day of May and ends on the last day of April. As an example, fiscal 2019, began on May 1, 2018 and concluded on April 30, 2019.

Q1 (July 31, 2021) Financial Statements

Q1 (September 29, 2021) MD&A

Q1 (July 31, 2020) Financial Statements

Q1 (July 31, 2020) MD&A

Q2 (October 31, 2020) Financial Statements

Q2 (October 31, 2020) MD&A

Q3 (January 31, 2021) Financial Statements

Q3 (January 31, 2021) MD&A

Q1 (July 31, 2019) Financial Statements

Q1 (July 31, 2019) MD&A

Q2 (October 31, 2019) Financial Statements

Q2 (October 31, 2019) MD&A

Q3 (January 31, 2020) Financial Statements

Q3 (January 31, 2020) MD&A

April 30, 2020 Audited Annual Financial Statements

April 30, 2020 MD&A

Q3 MD&A Quarter Ended January 31, 2019

Unaudited Interim Financial Statements – January 31, 2019 and January 31, 2018

Information Circular – October 11, 2018

Q2 MD&A Quarter Ended October 31, 2018

Unaudited Interim Financial Statements – October 31, 2018 and October 31, 2017

Q1 MD&A Quarter Ended July 31, 2018

Unaudited Interim Financial Statements – July 31, 2018 and July 31, 2017

Q1 Financial Statements Quarter Ended July 31, 2017

Q1 MD&A Quarter Ended July 31, 2017

Q2 Financial Statements Quarter Ended October 31, 2017

Q2 MD&A Quarter Ended October 31, 2017

Q1 Financial Statements Quarter Ended July 31, 2016

Q1 MD&A Quarter Ended July 31, 2016

Q2 Financial Statements Quarter Ended October 31, 2016

Q2 MD&A Quarter Ended October 31, 2016

Q3 Financial Statements Quarter Ended January 31, 2017

Q3 MD&A Quarter Ended January 31, 2017

Annual Audited Financial Statements Year Ended April 30, 2017

Annual MD&A Year Ended April 30, 2017

Q1 Financial Statements Quarter Ended July 31, 2015

Q1 MD&A Quarter Ended July 31, 2015

Q2 Financial Statements Quarter Ended October 31, 2015

Q2 MD&A Quarter Ended October 31, 2015

Q3 Financial Statements Quarter Ended January 31, 2016

Q3 MD&A Quarter Ended January 31, 2016

Annual Audited Financial Statements Year Ended April 30, 2016

Annual MD&A Year Ended April 30, 2016

Q1 Financial Statements Quarter Ended July 31, 2014

Q1 MD&A Quarter Ended July 31, 2014

Q2 Financial Statements Quarter Ended October 31, 2014

Q2 MD&A Quarter Ended October 31, 2014

Q3 Financial Statements Quarter Ended January 31, 2015

Q3 MD&A Quarter Ended January 31, 2015

Annual Audited Financial Statements Year Ended April 30, 2015

Annual MD&A Year Ended April 30, 2015

Additional historical reports are available on SEDAR.

Why invest in CYMAT

~|icon_datareport~|elegant-themes~|outline

Focus On Shareholder Value

~|icon_star_alt~|elegant-themes~|outline

Operational Excellence

~|icon_cog~|elegant-themes~|solid

Technology & Innovation